Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Current Value
$32.451 Year Return
Current Value
$32.451 Year Return
Market Cap
$1.85B
P/E Ratio
15.38
1Y Stock Return
18.24%
1Y Revenue Growth
25.83%
Dividend Yield
0.00%
Price to Book
3.1
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BDC | 53.14% | $4.79B | +72.83% | 0.17% |
PENG | 47.71% | $911.79M | +4.97% | 0.00% |
OPCH | 43.81% | $3.71B | -27.12% | 0.00% |
BLKB | 42.74% | $4.23B | +12.05% | 0.00% |
RGEN | 41.28% | $7.20B | -18.16% | 0.00% |
GPRO | 40.57% | $179.52M | -67.23% | 0.00% |
GIC | 40.28% | $1.04B | -25.63% | 3.67% |
SAGE | 39.70% | $300.36M | -74.61% | 0.00% |
TWO | 39.47% | $1.21B | -15.84% | 15.54% |
ANAB | 38.16% | $607.66M | +40.93% | 0.00% |
ARR | 37.07% | $1.05B | +8.10% | 16.27% |
TREE | 36.91% | $573.76M | +169.05% | 0.00% |
JAMF | 36.39% | $1.89B | -10.98% | 0.00% |
RVMD | 36.30% | $9.50B | +171.62% | 0.00% |
QRVO | 35.66% | $6.27B | -28.83% | 0.00% |
DX | 35.18% | $991.29M | +9.75% | 12.54% |
EDSA | 35.18% | $7.11M | -21.79% | 0.00% |
IVR | 34.82% | $495.56M | +2.38% | 19.70% |
CVLT | 34.51% | $7.37B | +136.34% | 0.00% |
DAN | 34.15% | $1.14B | -38.75% | 5.12% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BACK | 0.06% | $1.76M | -32.90% | 0.00% |
HP | 0.07% | $3.30B | -10.93% | 3.02% |
BRY | -0.15% | $323.14M | -39.04% | 10.40% |
ELD | 0.15% | $3.35B | +42.37% | 0.00% |
NNVC | 0.15% | $19.66M | +25.69% | 0.00% |
MCS | -0.15% | $669.85M | +49.35% | 1.28% |
K | -0.16% | $12.29B | +84.16% | 1.21% |
CYCN | -0.27% | $4.77M | -16.19% | 0.00% |
KMPR | -0.28% | $4.52B | +69.87% | 1.75% |
CAG | -0.28% | $12.64B | -6.10% | 5.26% |
NTR | -0.32% | $22.48B | -19.05% | 4.73% |
AU | -0.35% | $10.58B | +41.93% | 0.90% |
NFE | -0.36% | $2.29B | -74.75% | 3.32% |
POST | -0.36% | $6.45B | +28.40% | 0.00% |
CDRE | 0.37% | $1.30B | +1.85% | 1.10% |
BVN | 0.40% | $3.16B | +37.49% | 0.00% |
PULM | -0.42% | $19.83M | +202.98% | 0.00% |
PG | -0.42% | $402.15B | +14.14% | 2.33% |
HL | 0.42% | $3.63B | +21.79% | 0.58% |
OPRT | -0.45% | $112.95M | +40.81% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PGR | -23.99% | $149.10B | +57.29% | 0.45% |
RDDT | -21.20% | $24.08B | +303.41% | 0.00% |
GRMN | -17.67% | $39.82B | +73.79% | 1.43% |
HUSA | -17.44% | $16.69M | -11.56% | 0.00% |
SW | -17.09% | $13.78B | +15.02% | 1.14% |
PRPO | -15.18% | $9.10M | -13.65% | 0.00% |
PSQH | -15.02% | $79.26M | -57.46% | 0.00% |
DOGZ | -14.58% | $614.77M | +1,372.26% | 0.00% |
LPTH | -14.08% | $62.27M | +33.05% | 0.00% |
OMCL | -13.63% | $1.96B | +30.61% | 0.00% |
VIST | -12.76% | $4.75B | +67.10% | 0.00% |
SHEL | -12.67% | $205.19B | -1.07% | 4.20% |
TCTM | -11.93% | $8.10M | -42.99% | 0.00% |
SRPT | -11.20% | $10.18B | +26.81% | 0.00% |
GL | -11.14% | $9.18B | -8.60% | 0.86% |
BP | -11.11% | $77.24B | -18.61% | 6.32% |
COP | -10.83% | $130.16B | -1.63% | 2.59% |
JBI | -10.79% | $1.00B | -31.76% | 0.00% |
STKL | -9.76% | $894.47M | +55.49% | 0.00% |
MRO | -9.41% | $16.08B | +13.59% | 1.53% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XPH | 43.94% | $157.87M | 0.35% |
ARTY | 40.87% | $624.02M | 0.47% |
RIET | 40.67% | $88.96M | 0.5% |
VO | 40.54% | $73.70B | 0.04% |
REM | 40.19% | $632.41M | 0.48% |
MORT | 40.16% | $293.96M | 0.43% |
PCEF | 40.10% | $813.14M | 3.08% |
KBWY | 40.05% | $246.93M | 0.35% |
SIZE | 40.05% | $329.63M | 0.15% |
CGW | 40.02% | $962.52M | 0.56% |
SMMD | 39.97% | $1.24B | 0.15% |
FYX | 39.56% | $959.00M | 0.6% |
SPSM | 39.48% | $12.72B | 0.03% |
FXD | 39.47% | $1.54B | 0.61% |
ARKK | 38.69% | $6.28B | 0.75% |
XBI | 38.48% | $6.58B | 0.35% |
PTH | 38.31% | $143.31M | 0.6% |
QQA | 37.86% | $135.01M | 0% |
PBE | 37.70% | $258.53M | 0.58% |
XSLV | 37.69% | $322.27M | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTE | -0.11% | $1.70B | 0.07% |
TLTW | -0.36% | $1.09B | 0.35% |
TBIL | 0.61% | $4.38B | 0.15% |
CLOI | 0.68% | $715.40M | 0.4% |
GOVZ | 0.68% | $313.00M | 0.1% |
ICLO | -0.70% | $209.30M | 0.2% |
AGZD | 0.71% | $142.76M | 0.23% |
LTPZ | 0.81% | $715.65M | 0.2% |
PHDG | 0.89% | $113.97M | 0.39% |
DBA | 0.97% | $755.88M | 0.93% |
BOXX | -1.11% | $4.43B | 0.1949% |
DBB | 1.11% | $126.37M | 0.77% |
EDV | 1.17% | $3.88B | 0.06% |
TOTL | -1.21% | $3.31B | 0.55% |
ZROZ | 1.47% | $1.63B | 0.15% |
ULST | 1.55% | $535.47M | 0.2% |
IXC | 1.57% | $2.20B | 0.41% |
TPMN | -1.74% | $40.60M | 0.65% |
SOYB | 2.14% | $27.32M | 0.22% |
FTSM | 2.22% | $6.08B | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -29.92% | $388.04M | 1.43% |
VIXY | -26.43% | $195.31M | 0.85% |
TAIL | -17.12% | $67.98M | 0.59% |
DBE | -16.13% | $50.13M | 0.77% |
DBO | -16.10% | $217.57M | 0.77% |
COMT | -14.28% | $829.06M | 0.48% |
FTGC | -12.81% | $2.17B | 1.02% |
DBC | -12.14% | $1.39B | 0.87% |
GSG | -12.06% | $914.42M | 0.75% |
BCI | -12.04% | $1.20B | 0.26% |
PDBC | -11.88% | $4.40B | 0.59% |
USDU | -11.88% | $201.97M | 0.5% |
EQLS | -10.84% | $76.08M | 1% |
UUP | -10.59% | $309.25M | 0.77% |
USCI | -10.36% | $185.47M | 1.07% |
CTA | -10.35% | $350.27M | 0.78% |
HIGH | -9.81% | $302.78M | 0.51% |
GCC | -8.98% | $133.23M | 0.55% |
CMDY | -8.68% | $279.14M | 0.28% |
WEAT | -8.67% | $120.27M | 0.28% |
SeekingAlpha
November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.
SeekingAlpha
Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points
Yahoo
The most recent earnings report from Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY ) was disappointing for...
Yahoo
Shareholders might have noticed that Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY ) filed its quarterly result this...
Yahoo
HRMY vs. REGN: Which Stock Is the Better Value Option?
Yahoo
Harmony Biosciences Holdings ( NASDAQ:HRMY ) Third Quarter 2024 Results Key Financial Results Revenue: US$186.0m (up...
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.